Posted in | News | Renewable Energy | Wind Power

Energos Signs Development Agreements for Two Wind Power Projects

Facilitated by Allegiance Capital, Energos has signed agreements with the developers of two wind farm projects in west Texas. Energos, which is based in Madrid, will provide capital for development and development services to Peak Wind, L.L.C. and Caprock Wind. Both the wind power projects, Arranz Wind Tuxedo I and the Arranz Wind Caprock I, will generate about 200 MW of electricity each. Ongoing oversight services will be provided by Allegiance Capital for both the projects.

Fred McAllister, vice president at Allegiance Capital, said that Energos has much experience in the renewable energy development sector. The company was delighted to work with an investor who knows the opportunities and risks of wind energy development. To convert the status of the projects from their current "Greenfield" stage to “construction ready” stage, development support and capital are vital. Development for the projects has started and they are anticipated to commence production in 2014.

During the past 18 months, transactions for four renewable energy projects have been closed by Allegiance Capital. Currently, the company has many active engagements in electrical transmission and distribution and renewable energy sectors.

Fred McAllister said that Texas has long-term plans for the development of energy resources in the state. Renewable energy resources will play a key role for Texas’ energy needs in the future, he added. At present, regulations in Texas favor renewable energy sources. The state is facing challenges for power transmission and seeking ways to construct transmission lines to evacuate power from energy from renewable sources to other parts of the state.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.